Efficacy of TAK-085 in Participants With Hypertriglyceridemia
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the efficacy and safety of TAK-085, once daily
(QD) or twice daily (BID), compared to ethyl eicosapentaenoate (EPA-E), three times daily
(TID) in participants with hypertriglyceridemia undergoing lifestyle modification.